Position in FBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,922,978
+$5,169,219 QoQ
Shares Held
655,199
+93.9% QoQ
Ownership
3.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 85 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBRX Over Time
Shares Held
Position Value (USD)
Derivatives in FBRX
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$37,000
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. FBRX ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in FBRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,922,978 | 655,199 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $13,922,978 | 655,199 | Shares | Sole | 2026-07-16 | |
| 2026-06-04 | $17,727,817 | 1,062,182 | Shares | Sole | 2026-06-08 | |
| 2026-03-31 | $8,753,759 | 337,983 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,727,099 | 246,685 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,797,180 | 119,812 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $932,459 | 72,116 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $113,334 | 14,605 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $59,386 | 57,102 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $99,704 | 98,717 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,602 | 67,602 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $140,270 | 131,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $76,696 | 58,997 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $601,316 | 280,989 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $37,000 | 12,500 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $1,495,572 | 505,261 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $640,931 | 19,064 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,514,419 | 160,911 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,420,827 | 39,023 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||